L. Deng

发表

Identification of Special AT-Rich Sequence Binding Protein 1 as a Novel Tumor Antigen Recognized by CD8+ T Cells: Implication for Cancer Immunotherapy

Y. Li, Helen Y Wang, Rong-Fu Wang, 2013, PloS one.

Tumor antigen-specific CD8+ T cells are negatively regulated by PD-1 and Tim-3 in human gastric cancer.

Dan Li, Xuesong Liu, Jingpo Li, 2017, Cellular immunology.

Rapid identification of tumor-reactive T-cell receptors by RNA preamplification-based single-cell sequencing.

Dongjuan Qiao, Fenglan Liu, Hao Wu, 2022, Journal of immunological methods.

MMP9 mediates MICA shedding in human osteosarcomas

Dahui Sun, Xu Wang, L. Deng, 2011, Cell biology international.

Analysis of the expression of Fas, FasL and Bcl-2 in the pathogenesis of autoimmune thyroid disorders.

Yiping Luo, Wei Li, Haihua Huang, 2004, Cellular & molecular immunology.

Identification and assessment of TCR-T cells targeting an epitope conserved in SARS-CoV-2 variants for the treatment of COVID-19

M. Nielsen, Dongjuan Qiao, Fenglan Liu, 2022, International Immunopharmacology.

The MicroRNA-Based Strategies to Combat Cancer Chemoresistance via Regulating Autophagy

Yuhe Lei, Lei Chen, L. Deng, 2022, Frontiers in Oncology.

Tumor perivascular cell-derived extracellular vesicles promote angiogenesis via the Gas6/Axl pathway.

Q. Qi, W. Ye, Min-feng Chen, 2021, Cancer letters.

Targeting PD-1 and Tim-3 Pathways to Reverse CD8 T-Cell Exhaustion and Enhance Ex Vivo T-Cell Responses to Autologous Dendritic/Tumor Vaccines

Xuesong Liu, Jingpo Li, Zhaomin Yang, 2016, Journal of immunotherapy.

Up-Regulation of Kin17 Is Essential for Proliferation of Breast Cancer

T. Zeng, L. Deng, Yan Zhang, 2011, PloS one.